Total FY 2012 Revenue and Adjusted EBITDA* Increased 39% and 52% Respectively
ATLANTA, April 24, 2013 /PRNewswire/ -- Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of SaaS-based enterprise content management, business analytics, computer assisted coding (CAC), and clinical documentation improvement (CDI) solutions for healthcare providers, today announced financial results for the fourth quarter and fiscal year 2012, which ended January 31, 2013.
Revenues for the three-month period ended January 31, 2013, increased 49% to $6,738,000 versus $4,518,000 in the comparable period of fiscal 2011. The quarterly increase was primarily attributable to the Company's Collabra suite of coding and CDI solutions acquired as part of the Meta Health Technology, Inc. transaction completed in the third quarter of fiscal year 2012.
"We completed another very solid quarter of performance contributing to a very successful year," said Robert E. Watson, President and Chief Executive Officer of Streamline Health. "We realized many significant accomplishments during the year, all of which were made possible by remaining focused on developing and deploying meaningful solutions for our valued clients. Specifically, during the fourth quarter, revenue and adjusted EBITDA increased substantially; new sales bookings totaled $5.5 million; and maintenance and SaaS contract renewals totaled $2.3 million."
"For the year, revenue increased 39% over fiscal year 2011, and SaaS-based revenue increased 76%. Adjusted EBITDA improved 52% over last year, and we exited the fiscal year 2012 with our sales backlog up 86% to $51 million."
Highlights for the quarter and the fiscal year ended January 31, 2013 included:
- Revenue for the fourth quarter and the fiscal year 2012 was $6,738,000 and $23,767,000 respectively, an increase of 49% and 39% over comparable periods in 2011;
- Adjusted EBITDA* for fourth quarter and the fiscal year 2012 was $1.7 million and $6.6 million, respectively, an increase of 11% and 52% over comparable periods in 2011;
- Recorded net loss of $7,807,000 for the three-month period ended January 31, 2013, of which $5,913,000 was attributed to a loss on conversion of convertible notes and $779,000 attributed to non-recurring transaction related expenses, resulting in an adjusted non-GAAP net loss* of $1,115,000;
- Recorded net loss of $5,379,000 for the twelve-month period ended January 31, 2013, of which $5,970,000 was attributed to a loss on conversion of convertible notes and $1,940,000 was attributed to non-recurring transaction-related expenses, resulting in an adjusted non-GAAP net earnings* of $2,531,000;
- Software as a Service (SaaS) revenues for fiscal year 2012 increased 76% over 2011;
- Maintenance and support revenues for the quarter and the year increased $1.1 million and $2.3 million, respectively, over comparable periods in 2011;
- New sales bookings for the quarter were $5.5 million;
- Maintenance and SaaS contract renewals for the quarter were $2.3 million;
- Backlog at the end of the quarter was $51.0 million.
New sales bookings for the fourth quarter increased 83% to $5.5 million, compared to $3.0 million in the fourth quarter of 2011, primarily consisting of professional services and software as a service (SaaS) contracts. Maintenance and SaaS renewals or extensions were $2.3 million, as compared to $8.9 million in the fourth quarter of 2011. The decrease in renewals is due to the fact that several multi-year renewals were made in 2011.
Backlog at January 31, 2013 increased 86% to $51.0 million compared with $27.4 million at January 31, 2012. The increase in the current backlog reflects significant new SaaS contract signings as well as current clients purchasing additional solutions.
Conference Call Information
The Company will conduct a conference call and web cast to review the results on Wednesday, April 24, 2013 at 11:00 a.m. EDT. Interested parties can access the call by dialing 888-539-3696 and then entering the passcode 3463092. A live webcast will also be available by clicking this link: http://bit.ly/10z7Bp9
A replay of the conference call will be available from Wednesday, April 24, 2013 at 2:00 p.m. EDT to Monday, April 29, 2013 at 2:00 p.m. EDT by dialing 888-203-1112 and entering passcode 3463092.
* Non-GAAP Financial Measures
Streamline Health reports its financial results in accordance with generally accepted accounting principles in the United States ("GAAP"). Streamline Health's management also evaluates and makes operating decisions using various other measures. One such measure is adjusted EBITDA, which is a non-GAAP financial measure. Streamline Health's management believes that these measures provide useful supplemental information regarding the performance of Streamline Health's business operations.
Streamline Health defines "non-GAAP adjusted net earnings (loss)" as GAAP net earnings (loss), plus losses on conversion of convertible notes, transaction related expenses, and non-recurring operational costs.
Streamline Health defines "adjusted EBITDA" as net earnings (loss) plus interest expense, tax expense, depreciation and amortization expense of tangible and intangible assets, stock-based compensation expense, significant non-recurring operating expenses, and transactional related expenses including: gains and losses on debt and equity conversions, associate severances and related restructuring expenses, associate inducements, and professional and advisory fees . A table illustrating this measure is included in this publication.
About Streamline Health
Streamline Health Solutions, Inc. (NASDAQ: STRM) is a leading provider of SaaS-based healthcare information technology (HCIT) solutions for hospitals and physician groups with offices in Atlanta, Cincinnati and New York. The company's comprehensive suite of solutions includes: enterprise content management (ECM), business analytics, integrated workflow systems, clinical documentation improvement (CDI), and computer assisted coding (CAC). Across the revenue cycle, these solutions offer healthcare enterprises a flexible, customizable way to communicate between disparate departments and information systems to improve processes, boost productivity, and optimize clinical, administrative and financial performance. For more information, please visit our website at http://www.streamlinehealth.net.
Safe Harbor statement under the Private Securities Litigation Reform Act of 1995
Statements made by Streamline Health Solutions, Inc. that are not historical facts are forward-looking statements that are subject to risks and uncertainties and are no guarantee of future performance. The forward looking statements contained herein are subject to certain risks, uncertainties and important factors that could cause actual results to differ materially from those reflected in the forward-looking statements, included herein. These risks and uncertainties include, but are not limited to, the timing of contract negotiations and execution of contracts and the related timing of the revenue recognition related thereto, the potential cancellation of existing contracts or clients not completing projects included in the backlog, the impact of competitive products and pricing, product demand and market acceptance, new product development, key strategic alliances with vendors that resell the Company's products, the ability of the Company to control costs, availability of products obtained from third party vendors, the healthcare regulatory environment, potential changes in legislation, regulation and government funding affecting the healthcare industry, healthcare information systems budgets, availability of healthcare information systems trained personnel for implementation of new systems, as well as maintenance of legacy systems, fluctuations in operating results, effects of critical accounting policies and judgments, changes in accounting policies or procedures as may be required by the Financial Accountings Standards Board or other similar entities, changes in economic, business and market conditions impacting the healthcare industry, the markets in which the Company operates and nationally, and the Company's ability to maintain compliance with the terms of its credit facilities, and other risks detailed from time to time in the Streamline Health Solutions, Inc. filings with the U. S. Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward looking statements, which reflect management's analysis only as of the date hereof. The Company undertakes no obligation to publicly release the results of any revision to these forward-looking statements, which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
|
Company Contact: Ashley Moore Director, Marketing (404)-446-2057 |
Investor Contacts: Randy Salisbury Investor Relations (404)-229-4242 |
|
BPC Financial Marketing John Baldissera 800-368-1217 |
|
STREAMLINE HEALTH SOLUTIONS, INC. |
||||||||
|
Three Months Ended January 31, |
Fiscal Year Ended |
|||||||
|
2013 |
2012 |
2012 |
2011 |
|||||
|
Revenues: |
||||||||
|
Systems sales |
$ |
743,730 |
$ |
195,598 |
$ |
1,463,225 |
$ |
722,195 |
|
Professional services |
638,897 |
661,050 |
3,792,569 |
3,369,875 |
||||
|
Maintenance and support |
3,413,934 |
2,309,213 |
11,211,197 |
8,867,697 |
||||
|
Software as a service |
1,941,692 |
1,352,301 |
7,299,812 |
4,156,441 |
||||
|
Total revenues |
6,738,253 |
4,518,162 |
23,766,803 |
17,116,208 |
||||
|
Operating expenses: |
||||||||
|
Cost of systems sales |
810,469 |
486,009 |
2,747,230 |
2,237,899 |
||||
|
Cost of services, maintenance and |
||||||||
|
support |
2,072,870 |
1,254,658 |
6,333,566 |
4,830,117 |
||||
|
Cost of software as a service |
662,194 |
481,327 |
2,512,156 |
1,815,986 |
||||
|
Selling, general and administrative |
3,259,675 |
1,835,016 |
10,060,469 |
6,577,101 |
||||
|
Research and development |
1,114,448 |
344,845 |
2,948,313 |
1,408,749 |
||||
|
Total operating expenses |
7,919,656 |
4,401,855 |
24,601,734 |
16,869,852 |
||||
|
Operating income (loss) |
(1,181,403) |
116,307 |
(834,931) |
246,356 |
||||
|
Other income (expense): |
||||||||
|
Interest expense |
(567,849) |
(110,995) |
(1,957,010) |
(178,524) |
||||
|
Loss on conversion of convertible notes |
(5,913,320) |
- |
(5,970,002) |
- |
||||
|
Miscellaneous income (expenses) |
487,190 |
11,211 |
494,677 |
(30,943) |
||||
|
Earnings (loss) before income taxes |
(7,175,382) |
16,523 |
(8,267,266) |
36,889 |
||||
|
Income tax benefit (expense) |
(631,342) |
(12,000) |
2,888,537 |
(24,315) |
||||
|
Net earnings (loss) |
$ |
(7,806,724) |
$ |
4,523 |
$ |
(5,378,729) |
$ |
12,574 |
|
Less: deemed dividends on Series A Preferred Shares |
(36,915) |
(176,048) |
||||||
|
Net earnings (loss) attributable to common shareholders |
$ |
(7,843,639) |
$ |
(5,554,777) |
||||
|
Basic net earnings (loss) per common share |
$ |
(0.63) |
$ |
0.00 |
$ |
(0.48) |
$ |
0.00 |
|
Number of shares used in basic per common share computation |
12,492,611 |
9,645,140 |
11,634,540 |
9,887,841 |
||||
|
Diluted net earnings (loss) per common share |
$ |
(0.63) |
$ |
0.00 |
$ |
(0.48) |
$ |
0.00 |
|
Number of shares used in diluted per common share computation |
12,492,611 |
9,648,628 |
11,634,540 |
9,899,073 |
||||
|
STREAMLINE HEALTH SOLUTIONS, INC. CONDENSED CONSOLIDATED BALANCE SHEETS
Assets |
||||
|
January 31, |
||||
|
2013 |
2012 |
|||
|
Current assets: |
||||
|
Cash and cash equivalents |
$ |
7,500,256 |
$ |
2,243,054 |
|
Accounts receivable, net of allowance for doubtful |
||||
|
accounts of $134,000 and $100,000, respectively |
8,685,017 |
4,484,605 |
||
|
Contract receivables |
1,481,819 |
430,370 |
||
|
Prepaid hardware and third party software for future |
||||
|
delivery |
22,777 |
38,193 |
||
|
Prepaid client maintenance contracts |
1,080,330 |
788,917 |
||
|
Other prepaid assets |
997,024 |
256,104 |
||
|
Deferred income taxes |
- |
167,000 |
||
|
Other current assets |
110,555 |
- |
||
|
Total current assets |
19,877,778 |
8,408,243 |
||
|
Non-current assets: |
||||
|
Property and equipment: |
||||
|
Computer equipment |
3,420,452 |
2,892,885 |
||
|
Computer software |
2,196,236 |
2,131,730 |
||
|
Office furniture, fixtures and equipment |
843,274 |
756,375 |
||
|
Leasehold improvements |
697,570 |
667,000 |
||
|
7,157,532 |
6,447,990 |
|||
|
Accumulated depreciation and amortization |
(5,958,727) |
(5,232,321) |
||
|
Property and equipment, net |
1,198,805 |
1,215,669 |
||
|
Contract receivables, less current portion |
126,626 |
221,596 |
||
|
Capitalized software development costs, net of |
||||
|
accumulated amortization of $17,464,601 and |
||||
|
$14,805,236, respectively |
12,816,486 |
9,830,175 |
||
|
Intangible assets, net |
8,188,131 |
417,666 |
||
|
Deferred financing costs, net |
541,740 |
145,857 |
||
|
Goodwill |
12,133,304 |
4,060,504 |
||
|
Other, including deferred taxes of $0 and $711,000, |
||||
|
respectively |
383,708 |
841,348 |
||
|
Total non-current assets |
35,388,800 |
16,732,815 |
||
|
$ |
55,266,578 |
$ |
25,141,058 |
|
|
STREAMLINE HEALTH SOLUTIONS, INC.
Liabilities and Stockholders' Equity |
||||
|
January 31, |
||||
|
2013 |
2012 |
|||
|
Current liabilities: |
||||
|
Accounts payable |
$ |
1,495,913 |
$ |
879,027 |
|
Accrued compensation |
2,088,850 |
887,130 |
||
|
Accrued other expenses |
1,325,039 |
479,526 |
||
|
Deferred revenues |
9,810,442 |
6,496,938 |
||
|
Contingent consideration for earn-out |
1,319,559 |
- |
||
|
Current portion of long-term debt |
1,250,000 |
- |
||
|
Current portion of deferred tax liability |
35,619 |
- |
||
|
Total current liabilities |
17,325,422 |
8,742,621 |
||
|
Non-current liabilities: |
||||
|
Term loans, less current portion |
12,437,501 |
4,120,000 |
||
|
Convertible note |
- |
3,000,000 |
||
|
Warrants liability |
3,649,349 |
- |
||
|
Lease incentive liability, less current portion |
99,579 |
47,193 |
||
|
Contingent consideration for earn-out, less current portion |
- |
1,232,720 |
||
|
Deferred income tax liability, less current portion |
529,709 |
- |
||
|
Total non-current liabilities |
16,716,138 |
8,399,913 |
||
|
Total liabilities |
34,041,560 |
17,142,534 |
||
|
Series A 0% Convertible Redeemable Preferred Stock, $.01 par |
||||
|
value per share, $11,999,985 redemption value, 4,000,000 |
||||
|
shares authorized, 3,999,995 issued and outstanding, net of |
||||
|
unamortized preferred stock discount of $4,234,269 |
7,765,716 |
- |
||
|
Stockholders' equity: |
||||
|
Common stock, $.01 par value per share, 25,000,000 shares |
||||
|
authorized, 12,643,620 and 10,433,716 shares issued and |
||||
|
outstanding, respectively |
126,436 |
104,338 |
||
|
Convertible redeemable preferred stock, $.01 par value per |
||||
|
share, 1,000,000 shares authorized, no shares issued |
- |
- |
||
|
Additional paid in capital |
49,178,389 |
38,360,980 |
||
|
Accumulated deficit |
(35,845,523) |
(30,466,794) |
||
|
Total stockholders' equity |
13,459,302 |
7,998,524 |
||
|
$ |
55,266,578 |
$ |
25,141,058 |
|
|
STREAMLINE HEALTH SOLUTIONS, INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
Twelve Months Ended January 31, |
||||
|
2013 |
2012 |
|||
|
Operating activities: |
||||
|
Net earnings (loss) |
$ |
(5,378,729) |
$ |
12,574 |
|
Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities, net of effect of acquisitions: |
||||
|
Depreciation |
726,406 |
727,794 |
||
|
Amortization of capitalized software development costs |
2,659,365 |
1,972,889 |
||
|
Amortization of intangible assets |
583,535 |
2,334 |
||
|
Amortization of other deferred costs |
241,478 |
11,643 |
||
|
Amortization of debt discount |
111,583 |
- |
||
|
Valuation adjustment for warrants liability |
(489,434) |
- |
||
|
Deferred tax benefit |
(2,999,284) |
- |
||
|
Valuation adjustment for contingent earn-out |
86,839 |
- |
||
|
Net loss from conversion of convertible notes |
5,970,002 |
- |
||
|
Loss on disposal of fixed assets |
- |
26,667 |
||
|
Share-based compensation expense |
956,144 |
894,800 |
||
|
Provision for accounts receivable |
67,464 |
159,000 |
||
|
Changes in assets and liabilities, net of assets acquired: |
||||
|
Accounts and contract receivables |
(2,923,242) |
(1,485,634) |
||
|
Other assets |
(1,129,255) |
(47,081) |
||
|
Accounts payable |
526,149 |
202,395 |
||
|
Accrued expenses |
1,056,047 |
(311,449) |
||
|
Deferred revenues |
(180,200) |
730,143 |
||
|
Net cash provided by (used in) operating activities |
(115,132) |
2,896,075 |
||
|
Investing activities: |
||||
|
Purchases of property and equipment |
(576,736) |
(408,064) |
||
|
Capitalization of software development costs |
(1,999,676) |
(2,600,000) |
||
|
Payment for acquisition |
(12,161,614) |
(2,124,479) |
||
|
Net cash used in investing activities |
(14,738,026) |
(5,132,543) |
||
|
Financing activities: |
||||
|
Proceeds from term loans |
9,880,000 |
4,120,000 |
||
|
Principal repayments on term loans |
(312,500) |
- |
||
|
Proceeds from private placement |
12,000,000 |
- |
||
|
Payment of deferred financing costs |
(1,271,862) |
(157,500) |
||
|
Net change under revolving credit facility |
- |
(1,200,000) |
||
|
Proceeds from exercise of stock options and stock purchase plan |
282,628 |
92,722 |
||
|
Proceeds from stock sale |
- |
403,988 |
||
|
Payment of success fee |
(467,906) |
- |
||
|
Payments on capital lease |
- |
(183,637) |
||
|
Net cash provided by financing activities |
20,110,360 |
3,075,573 |
||
|
Increase in cash and cash equivalents |
5,257,202 |
839,105 |
||
|
Cash and cash equivalents at beginning of year |
2,243,054 |
1,403,949 |
||
|
Cash and cash equivalents at end of year |
$ |
7,500,256 |
$ |
2,243,054 |
|
Supplemental cash flow disclosures: |
||||
|
Interest paid |
$ |
1,626,750 |
$ |
92,431 |
|
Income taxes paid |
$ |
84,990 |
$ |
20,136 |
|
Supplemental disclosure of non-cash financing activities: |
||||
|
Convertible note payable issued in conjunction with acquisition |
$ |
- |
$ |
3,000,000 |
|
Conversion of $3,000,000 note payable, Interpoint to common shares |
3,116,182 |
- |
||
|
Issuance of 393,086 shares of common stock, as part of Meta purchase price |
1,501,609 |
- |
||
|
Deemed dividends on Series A Preferred Stock |
176,048 |
- |
||
|
Issuance of warrants to placement agents |
753,737 |
- |
||
|
Reclassification of warrants from equity to warrants liability |
4,138,783 |
- |
||
|
Conversion of notes issued in conjunction with the private placement to Series A Preferred Stock, at fair value |
9,182,562 |
- |
||
|
STREAMLINE HEALTH SOLUTIONS, INC. Backlog (Unaudited) Table A |
||||||
|
Backlog |
||||||
|
January 31, 2013 |
October 31, 2012 |
January 31, 2012 |
||||
|
Streamline Health Software Licenses |
$ |
3,416,000 |
$ |
3,650,000 |
$ |
181,000 |
|
Hardware and Third Party Software |
100,000 |
84,000 |
194,000 |
|||
|
Professional Services |
4,527,000 |
4,348,000 |
5,945,000 |
|||
|
Software as a Service |
20,439,000 |
19,117,000 |
10,542,000 |
|||
|
Maintenance and Support |
22,504,000 |
21,535,000 |
10,504,000 |
|||
|
Total |
$ |
50,986,000 |
$ |
48,734,000 |
$ |
27,366,000 |
|
STREAMLINE HEALTH SOLUTIONS, INC. New Bookings (Unaudited) Table B |
||||
|
New bookings (1) |
||||
|
Three Months Ended |
||||
|
January 31, 2013 |
||||
|
Value |
% of Total Bookings |
|||
|
Streamline Health Software licenses |
$ |
555,000 |
10% |
|
|
Software as a Service |
2,930,000 |
54% |
||
|
Maintenance and Support |
771,000 |
14% |
||
|
Professional Services |
1,138,000 |
21% |
||
|
Hardware & Third Party Software |
73,000 |
1% |
||
|
Total Bookings |
$ |
5,467,000 |
100% |
|
|
Twelve Months Ended |
||||
|
January 31, 2013 |
||||
|
Value |
% of Total Bookings |
|||
|
Streamline Health Software licenses |
$ |
709,000 |
4% |
|
|
Software as a Service |
13,150,000 |
70% |
||
|
Maintenance and Support |
947,000 |
5% |
||
|
Professional Services |
3,612,000 |
19% |
||
|
Hardware & Third Party Software |
324,000 |
2% |
||
|
Total Bookings |
$ |
18,742,000 |
100% |
|
|
(1) |
Bookings are the aggregate of signed contracts and/or completed customer purchase orders approved and accepted by the Company as binding commitments to purchase its products and/or services. New bookings do not include maintenance services as these tend to be recurring in nature on an annual or more frequent basis. |
|
Reconciliation of Non-GAAP Financial Measures |
|
This press release contains a non-GAAP financial measure under the rules of the U.S. Securities and Exchange Commission for adjusted EBITDA. This non-GAAP information supplements and is not intended to represent a measure of performance in accordance with disclosures required by generally accepted accounting principles. Non-GAAP financial measures are used internally to manage the business, such as in establishing an annual operating budget. Non-GAAP financial measures are used by Streamline Health's management in its operating and financial decision-making because management believes these measures reflect ongoing business in a manner that allows meaningful period-to-period comparisons. Accordingly, the Company believes it is useful for investors and others to review both GAAP and non-GAAP measures in order to (a) understand and evaluate current operating performance and future prospects in the same manner as management does and (b) compare in a consistent manner the company's current financial results with past financial results. The primary limitations associated with the use of non-GAAP financial measures are that these measures may not be directly comparable to the amounts reported by other companies and they do not include all items of income and expense that affect operations. The Company's management compensates for these limitations by considering the company's financial results and outlook as determined in accordance with GAAP and by providing a detailed reconciliation of the non-GAAP financial measures to the most directly comparable GAAP measures in the tables attached to this press release. Streamline Health defines "adjusted EBITDA" as net earnings (loss) plus interest expense, tax expense, depreciation and amortization expense of tangible and intangible assets, stock-based compensation expense, significant non-recurring operating expenses, and transactional related expenses including: gains and losses on debt and equity conversions, associate severances and related restructuring expenses, associate inducements, professional and advisory fees, and internal direct costs incurred to complete transactions. |
|
Reconciliation of net earnings (loss) to non-GAAP adjusted EBITDA (in thousands) |
||||||||
|
Adjusted EBITDA Reconciliation |
Three Months Ended, |
Twelve Months Ended, |
||||||
|
January 31, 2013 |
January 31, 2012 |
January 31, 2013 |
January 31, 2012 |
|||||
|
Net earnings (loss) |
$ |
(7,807) |
$ |
5 |
$ |
(5,379) |
$ |
13 |
|
Interest expense |
568 |
111 |
1,957 |
179 |
||||
|
Income tax expense (benefit) |
632 |
12 |
(2,888) |
24 |
||||
|
Depreciation |
179 |
189 |
726 |
728 |
||||
|
Amortization of capitalized software development costs |
728 |
504 |
2,659 |
1,973 |
||||
|
Amortization of intangible assets |
314 |
2 |
584 |
2 |
||||
|
Amortization of other costs |
35 |
11 |
35 |
11 |
||||
|
EBITDA |
(5,351) |
834 |
(2,306) |
2,930 |
||||
|
Share-based compensation expense |
312 |
366 |
956 |
895 |
||||
|
Loss on conversion of convertible notes |
5,913 |
- |
5,970 |
- |
||||
|
Transaction related professional fees, advisory fees and other internal direct costs |
- |
195 |
796 |
195 |
||||
|
Associate severances and other costs relating to transactions or corporate restructuring |
588 |
100 |
866 |
307 |
||||
|
Other non-recurring operating expenses |
191 |
- |
278 |
- |
||||
|
Adjusted EBITDA |
$ |
1,653 |
$ |
1,495 |
$ |
6,560 |
$ |
4,327 |
|
Adjusted EBITDA per diluted share |
||||||||
|
Earnings (loss) per share - diluted |
$ |
(0.63) |
$ |
0.00 |
$ |
(0.48) |
$ |
0.00 |
|
Adjusted EBITDA per adjusted diluted share (1) |
$ |
0.09 |
$ |
0.16 |
$ |
0.46 |
$ |
0.44 |
|
Diluted weighted average shares |
12,492,611 |
9,645,000 |
11,634,540 |
9,899,073 |
||||
|
Includable incremental shares – adjusted EBITDA (2) |
5,090,421 |
- |
494,109 |
- |
||||
|
Adjusted diluted shares |
17,583,032 |
9,645,000 |
12,128,649 |
9,899,073 |
||||
|
(1) |
Adjusted EBITDA per adjusted diluted share for the Company's common stock is computed using the more dilutive of the two-class method or the if-converted method. |
|
(2) |
The number of incremental shares that would be dilutive under profit assumption, only applicable under a GAAP net loss. If GAAP profit is earned in the current period, no additional incremental shares are assumed. |
SOURCE Streamline Health Solutions, Inc.